Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$93.0K
15.50K shares
What this filing means
PERSKY MARLA plans to sell 15.50K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $93.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/3/2026ACC: 0001950047-26-005565
Director
Since Oct 2021
15.50K
Shares to sell
$93.0K
Approx. market value
15.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/3/2026
15.50KTotal acquired15.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2026 | Restricted Stock Units N/A | 15.50K | — |
| Total | 15.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15.50K
Market value
$93.0K
6/3/2026
Total
Units
15.50K
Value
$93.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/3/2026 | 15.50K | $93.0K | NASDAQ | Planned |
| Total | 15.50K | $93.0K | ||